Atrial fibrillation, anticoagulation, and shared decision-making;Fibrillation auriculaire et partage avec le patient de la décision d'anticoaguler

Medecine et Hygiene

Volumn 60, Issue 2412, 2002, Pages 2054-2058

  Nendaz, Mathieu ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULANT THERAPY; ANXIETY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL DECISION MAKING; PATIENT INFORMATION; PATIENT SATISFACTION;

EID: 0037032494     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501.
2. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-70.
3. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-9.
4. Albers GW, Bittar N, Young L, et al. Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals. Neurology 1997; 48: 1598-604.
5. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000; 160: 41-6.
6. Man-Son-Hing M, Laupacis A, O'Connor A, et al. Warfann for atrial fibrillation. The patient's perspective. Arch Intern Med 1996; 156:1841-8.
7. Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study. BMJ 2001; 323: 1218-22.
8. Thomson R, Parkin D, Eccles M, Sudlow M, Robinson A. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 2000; 355: 956-62.
9. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: Observational study of patient based decision analysis. BMJ 2000; 320: 1380-4.
10. Thomson R, Robinson A, Greenaway J, Lowe P. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Qual Saf Health Care 2002; 11: 25-31.
11. Man-Son-Hing M, Laupacis A, O'Connor AM, et al. Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med 2000; 15: 723-30.
12. O'Connor A, Stacey D, Rovner D, et al. Decision aids for people facing health treatment or screening decisions (Cochrane Review). The Cochrane Library, Issue 2. Oxford: Update Software, 2002.
13. Man-Son-Hing M, Laupacis A, O'Connor AM, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: A randomized controlled trial. JAMA 1999; 282: 737-43.
14. Lip GY, Kamath S, Jafri M, Mohammed A, Bareford D. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: The West Birmingham Atrial Fibrillation Project. Stroke 2002; 33: 238-42.
15. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: Is the information good enough? BMJ 1999; 318: 318-22.